Stifel Reiterates Buy Rating on Medtronic, Inc. (MDT) Following CFO Meeting

September 26, 2022 8:15 AM EDT Send to a Friend
Stifel analyst Rick Wise reiterated a Buy rating and $105.00 price target on Medtronic, Inc. (NYSE: MDT) following a visit ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login